Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus

Biochemical Pharmacology

Volumn 55, Issue 8, 1998, Pages 1139-1149

  Rabinovitch, A ^a   Suarez Pinzon, W L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autoimmunity; Cytokines; Free radicals; Insulin dependent diabetes mellitus; Islet cell; Nitric oxide

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOTOXIN;

ARTICLE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LANGERHANS CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0032523104     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00492-9     Document Type: Article

References (116)

1. J.F. Bach Insulin-dependent diabetes mellitus as an autoimmune disease Endocr Rev 15 1994 516 542
2. B. Singh A. Rabinovitch Influence of microbial agents on the development and prevention of autoimmune diabetes Autoimmunity 15 1993 209 213
3. A. Rabinovitch Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43 1994 613 621
4. T.R. Mosmann R.L Coffman TH1 and TH2 cells Different patterns of lymphokine secretion lead to different functional properties Annu Rev Immunol 7 1989 145 173
5. F. Powrie R.L Coffman Cytokine regulation of T-cell function Potential for therapeutic intervention Immunol Today 14 1993 270 274
6. S. Romagnani TH1 and TH2 subsets Regulation of differentiation and role in protection and immunopathology Int Arch Allergy Immunol 98 1992 279 285
7. T. Mandrup-Poulsen S. Helqvist L.D Wogensen J. Mølvig F. Pociot J. Johannesen J. Nerup Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells Curr Top Microbiol Immunol 164 1990 169 193
8. A. Rabinovitch Roles of cytokines in IDDM pathogenesis and islet β-cell destruction Diabetes Rev 1 1993 215 240
9. D. Pipeleers M. Van de Winkel Pancreatic β cells possess defense mechanisms against cell-specific toxicity Proc Natl Acad Sci USA 83 1986 5267 5271
10. Z. Ling In’t Veld PA and Pipeleers DG, Interaction of interleukin-1 with islet β-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression Diabetes 42 1993 56 65
11. R. Sutton D.W.R. Gray P. McShane M.J Dallman P.J Morris The specificity of rejection and the absence of susceptibility of pancreatic islet β-cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat J Exp Med 170 1989 751 762
12. O. Korsgren L. Jansson Characterization of mixed syngeneic-allogeneic and syngeneic-xenogeneic islet-graft rejections in mice Evidence of functional impairment of the remaining syngeneic islets in xenograft rejections J Clin Invest 93 1994 1113 1119
13. A. Rabinovitch W.L Suarez-Pinzon O. Sorensen R.C Bleackley R.F. Power IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice J Immunol 154 1994 4874 4882
14. A. Muir A. Peck M. Clare-Salzler Y.-H Song J. Cornelius R. Luchetta J. Krischer N. Maclaren Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription J Clin Invest 95 1995 628 634
15. N. Sarvetnick J. Shizuru D. Liggitt L. Martin B. McIntyre A. Gregory T. Parslow T. Stewart Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ Nature 346 1990 844 847
16. I.L Campbell T.W.H Kay L. Oxbrow L.C Harrison Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice J Clin Invest 87 1991 739 742
17. M. Debray-Sachs C. Carnaud C. Boitard H. Cohen I. Gresser P. Bedossa J.-F Bach Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ J Autoimmun 4 1991 237 248
18. F. Nicoletti P.L Meroni S. Landolfo M. Gariglio S. Guzzardi W. Barcellini M. Lunetta L. Mughini C. Zanussi Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ Lancet 336 1990 319
19. A.K Foulis M. McGill M.A Farquharson Insulitis in type I (insulin-dependent) diabetes mellitus in man Macrophages, lymphocytes, and interferon-γ containing cells J Pathol 164 1991 97 103
20. A.K Foulis M.A Farquharson A. Meager Immunoreactive α-interferon in insulin-secreting β-cells in type I diabetes mellitus Lancet 2 1987 1423 1427
21. X. Huang J. Yuan A. Goddard A. Foulis R.F.L James .Å Lernmark R. Pujol-Borrell A. Rabinovitch N. Somoza T.A Stewart Interferon expression in the pancreases of patients with type I diabetes Diabetes 44 1995 658 664
22. X. Huang B. Hultgren N. Dybdal T.A Stewart Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice Immunity 1 1994 469 478
23. T.A Stewart B. Hultgren X. Huang S. Pitts-Meek J. Hully N.J MacLachlan Induction of type 1 diabetes by interferon-α in transgenic mice Science 260 1993 1942 1946
24. J. Allison L. Oxbrow J.F.A.P. Miller Consequences of in situ production of IL-2 for islet cell death Int Immunol 6 1994 541 549
25. L. Wogensen M.-S Lee N. Sarvetnick Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice J Exp Med 179 1994 1379 1384
26. P.S. Ohashi S. Oehen P. Aichele B. Odermatt P. Herrera Y. Higuchi K. Higuchi K. Buerki H. Hengartner R.M. Zinkernagel Induction of diabetes is influenced by the infectious virus and local expression of MHC class 1 and tumor necrosis factor-α J Immunol 150 1993 5185 5194
27. S. Guerder D.E Picarella P.S. Linsley R.A Flavell Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice Proc Natl Acad Sci USA 91 1994 5138 5142
28. D.E Picarella A. Kratz C.-B Li N.H Ruddle R.A Flavell Insulitis in transgenic mice expressing tumor necrosis factor β (lymphotoxin) in the pancreas Proc Natl Acad Sci USA 89 1992 10036 10040
29. C.A Wilson C. Jacobs P. Baker D.G Baskin S. Dower Å Lernmark B. Toivola S. Vertrees D. Wilson IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat J Immunol 144 1990 3784 3788
30. C.O Jacob S. Asiso S.A Michie H.O McDevitt H. Acha-Orbea Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF) Similarities between TNFα and interleukin-1 Proc Natl Acad Sci USA 87 1990 968 972
31. D.V Serreze K. Hamaguchi D.H Leiter Immunostimulation circumvents diabetes in NOD/Lt mice J Autoimmun 2 1989 759 776
32. J. Zielasek V. Burkart P. Naylor A. Goldstein U. Kiesel H. Kolb Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats Immunology 69 1990 209 214
33. M.J Rapoport A. Jaramillo D. Zipris A.H Lazarus D.V Serreze D.H Leiter P. Cyopick J.S. Danska T.L Delovitch IL-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice J Exp Med 178 1993 87 99
34. K.J Pennline E. Roque-Gaffney M. Monahan Recombinant human IL-10 (rHU IL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse Clin Immunol Immunopathol 71 1994 169 175
35. J. Satoh H. Seino T. Abo S.-I Tanaka S. Shintani S. Ohta T. Sawai T. Nobunaga T. Oteki K. Kumagai T. Toyota Recombinant human tumor necrosis factor-α suppresses autoimmune diabetes in nonobese diabetic mice J Clin Invest 84 1989 1345 1348
36. J. Satoh H. Seino S. Shintani S.-I Tanaka T. Ohteki T. Masada T. Nobunaga T. Oteki K. Kumagai T. Toyota Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α J Immunol 145 1990 1395 1399
37. H. Seino K. Takahashi J. Satoh X.P Zhu M. Sagara T. Masuda T. Nobunaga I. Funahashi T. Kajikawa T. Toyota Prevention of autoimmune diabetes with lymphotoxin in NOD mice Diabetes 42 1993 398 404
38. K. Takahashi J. Satoh H. Seino X.P Zhu M. Sagara T. Masuda T. Toyota Prevention of type I diabetes with lymphotoxin in BB rats Clin Immunol Immunopathol 69 1993 318 323
39. D.V Serreze E.H Leiter Defective activation of T suppressor cell function in nonobese diabetic mice Potential relation to cytokine deficiencies J Immunol 140 1988 3801 3807
40. P.H Lapchak L.J Guilbert A. Rabinovitch Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund’s adjuvant A possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes Clin Immunol Immunopathol 65 1992 129 134
41. S. Reichlin Neuroendocrine–immune interactions N Engl J Med 329 1993 1246 1253
42. J.I Reimers L. Mørch H. Markholst L.D Wogensen H.U Andersen T. Mandrup-Poulsen J. Nerup Interleukin-1β (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats Autoimmunity 17 1994 105 118
43. V.E Kelley G.N Gaulton M. Hattori H. Ikegami G. Eisenbarth T.B Strom Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis J Immunol 140 1988 59 61
44. A. Pacheco-Silva M.G Bastos R.A Muggia O. Pankewycz J. Nichols J.R. Murphy T.B Strom Interleukin-2 receptor targeted fusion toxin (DAB480-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice Eur J Immunol 22 1992 697 702
45. M.G Cavallo P. Pozzilli C. Bird M. Wadhwa A. Meager N. Visalli A.J Gearing D. Andreani R. Thorpe Cytokines in sera from insulin-dependent diabetic patients at diagnosis Clin Exp Immunol 86 1991 256 259
46. A. Ciampolillo E. Guastamacchia L. Caragiulo G. Lollino O. De Robertis V. Lattanzi R. Giorgino in vitro secretion of interleukin-1β and interferon-γ by peripheral blood lymphomononuclear cells in diabetic patients Diabetes Res Clin Pract 21 1993 87 93
47. + T cells and their roles in the induction and prevention of autoimmunity Immunol Rev 123 1991 37 64
48. + T cell subset that inhibits this autoimmune potential J Exp Med 177 1993 627 636
49. + Th1 and Th2 T cells derived from the spleens of diabetic NOD mice J Clin Invest 95 1995 2979 2985
50. J.D Katz C. Benoist D. Mathis T helper cell subsets in insulin-dependent diabetes Science 268 1995 1185 1188
51. F.W. Fitch M.D McKisic D.W. Lancki T.F. Gajewski Differential regulation of murine T lymphocyte subsets Annu Rev Immunol 11 1993 29 48
52. + T cells Annu Rev Immunol 12 1994 635 673
53. K.V Moore A. O’Garra R. de Waal Malefyt P. Vieira T.R. Mosmann Interleukin 10 Annu Rev Immunol 11 1993 165 190
54. + T cells through IL-12 produced by Listeria -induced macrophages Science 260 1993 547 549
55. P. Scott IL-12 Initiation cytokine for cell-mediated immunity Science 260 1993 496 497
56. C.-S Hsieh A.B Heimberger J.S. Gold A. O’Garra K.M. Murphy Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system Proc Natl Acad Sci USA 89 1992 6065 6069
57. + T cells from T cell receptor transgenic mice J Exp Med 176 1992 1091 1098
58. S. Trembleau G. Penna E. Bosi A. Mortara M.K Gately L. Adorini Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice J Exp Med 181 1995 817 821
59. S. Trembleau G. Penna S. Gregori T. Magram M.K Gately L. Adorini The role of endogenous IL-12 in the development of spontaneous diabetes in NOD mice Autoimmunity 21 1995 23
60. G. Trinchieri Interleukin-12 A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Annu Rev Immunol 13 1995 251 276
61. B. Hultgren X. Huang N. Dybdal T.A Stewart Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice Diabetes 45 1996 812 817
62. A. Rabinovitch W.L Suarez-Pinzon O. Sorensen R.C Bleackley Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice Identification of iNOS expressing cells and relationships to cytokines expressed in the islets Endocrinology 137 1996 2093 2099
63. K.-D Kroncke V. Kolb-Bachofen B. Berschick V. Burkart H. Kolb Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation Biochem Biophys Res Commun 175 1991 752 758
64. J.A Corbett M.L McDaniel Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase J Exp Med 181 1995 559 568
65. J.A Corbett M.L McDaniel Does nitric oxide mediate autoimmune destruction of β-cells? Diabetes 41 1992 897 903
66. W.J Malaisse F. Malaisse-Lagae A. Sener D.G Pipeleers Determinants of the selective toxicity of alloxan to the pancreatic β cell Proc Natl Acad Sci USA 79 1982 927 930
67. K. Asayama N.W. Kooy I.M. Burr Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets Decrease of islet manganosuperoxide dismutase J Lab Clin Med 107 1986 459 464
68. S. Lenzen J. Drinkgern M. Tiedge Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues Free Radic Biol Med 20 1996 463 466
69. F. Pisanti S. Frascatore G. Papacio Superoxide dismutase activity in the BB rat A dynamic time–course study Life Sci 43 1988 1625 1632
70. G. Papaccio S. Franscatore F. Pisanti M. Latronico T. Linn Superoxide dismutase in the nonobese diabetic (NOD) mouse A dynamic time–course study Life Sci 56 1995 2223 2228
71. I.G Cornelius B.G Luttge A.B Peck Anti-oxidant enzyme activities in IDD prone and IDD resistant mice A comparative study Free Radic Biol Med 14 1993 409 420
72. I.N Nomikos S.J Prowse P. Carotenuto K.J Lafferty Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice Diabetes 35 1986 1302 1304
73. 2 radicals in autoimmune diabetes Immunol Cell Biol 67 1989 85 87
74. W.A Behrens F.W. Scott R. Madere K. Trick K. Hanna Effect of dietary vitamin E in the vitamin E status in the BB rat during development and after the onset of diabetes Ann Nutr Metab 30 1986 157 165
75. A.R. Hayward M. Shriber R. Sokol Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice J Lab Clin Med 119 1992 503 507
76. A.L Drash W.A Rudert S. Borguaye R. Wang I. Lieberman Effect of probucol on development of diabetes mellitus in BB rats Am J Cardiol 62 1988 27B 30B
77. A. Rabinovitch W.L Suarez R.F. Power Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice Life Sci 51 1992 1937 1943
78. A. Rabinovitch W.L Suarez R.F. Power Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice J Lab Clin Med 121 1993 603 607
79. A.M. Roza D.P Slakey G.M. Pieper T.M. Van Ye G. Moore-Hilton R.A Komorowski C.P Johnson B.E Hedlund M.B Adams Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats J Lab Clin Med 123 1994 556 560
80. W. Sumoski H. Baquerizo A. Rabinovitch Oxygen free radical scavengers protect rat islet cells from damage by cytokines Diabetologia 32 1989 792 796
81. A. Rabinovitch W.L Suarez P.D Thomas K. Strynadka I. Simpson Cytotoxic effects of cytokines on rat islets Evidence for involvement of free radicals and lipid peroxidation Diabetologia 35 1992 409 413
82. A. Rabinovitch W.L Suarez-Pinzon K. Strynadka J.R.T Lakey R.V Rajotte Human pancreatic islet β-cell destruction by cytokines involves oxygen free radicals and aldehyde production J Clin Endocrinol Metab 81 1996 3197 3202
83. S. Sandler K. Bendtzen L.A Hakan-Borg D.L Eizirik E. Strandell N. Welsh Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1β indicate a perturbation in the mitochondrial function Endocrinology 124 1989 1492 1501
84. P. Hammonds M. Beggs G. Beresford J. Espinal J. Clarke R.J Mertz Insulin-secreting β-cells possess specific receptors for interleukin-1β FEBS Lett 261 1990 97 100
85. C. Nathan S. Tsunawaki Secretion of toxic oxygen products by macrophages Regulatory cytokines and their effects on the oxidase Ciba Found Symp 118 1986 211 230
86. S.L Marklund Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts J Biol Chem 267 1992 6696 6701
87. W.L Suarez-Pinzon K. Strynadka A. Rabinovitch Destruction of rat pancreatic islet β-cells by cytokines involves the production of cytotoxic aldehydes Endocrinology 137 1996 5290 5296
88. S. Moncada R.M.J Palmer E.A Higgs Nitric oxide Physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
89. C. Southern D. Schulster I.C Green Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an l -arginine-dependent nitric oxide generating mechanism FEBS Lett 276 1990 42 44
90. S.G Laychock M.E Modica C.T Cavanaugh l -Arginine stimulates cyclic guanosine 3′,5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells Evidence for l -arginine:nitric oxide synthase Endocrinology 129 1991 3043 3052
91. J.A Corbett J.R. Lancaster Jr M.A Sweetland M.L McDaniel Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans J Biol Chem 266 1991 21351 21354
92. J.A Corbett J.L Wang M.A Sweetland J.R. Lancaster Jr M.L McDaniel Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide J Clin Invest 90 1992 2384 2391
93. W.L Suarez-Pinzon K. Strynadka R. Schulz A. Rabinovitch Mechanisms of cytokine-induced destruction of rat insulinoma cells The role of nitric oxide Endocrinology 134 1994 1006 1010
94. A. Rabinovitch W.L Suarez-Pinzon K. Strynadka R. Schulz J.R.T Lakey G.L Warnock R.V Rajotte Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production J Clin Endocrinol Metab 79 1994 1058 1062
95. D.L Eizirik S. Sandler N. Welsh M. Cetkovic-Cvrlje A. Nieman D.A Geller D.G Pipeleers K. Bendtzen C. Hellerström Cytokines suppress human islet function irrespective of their effects on nitric oxide generation J Clin Invest 93 1994 1968 1974
96. J. Beckman T. Beckman J. Chen P. Marshall B. Freeman Apparent hydroxyl radical production by peroxynitrite Implications for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci USA 87 1990 1620 1624
97. W.A Pryor G.L Squadrito The chemistry of peroxynitrite A product from the reaction of nitric oxide with superoxide Am J Physiol 268 1995 L699 L722
98. H. Kaur B. Halliwell Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients FEBS Lett 350 1994 9 12
99. J.P Crow J.S. Beckman The role of peroxynitrite in nitric oxide-mediated toxicity Curr Top Microbiol Immunol 196 1995 57 73
100. C. Szabó The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury Shock 6 1996 79 88
101. C.A Delaney B. Tyrberg L. Bouwens H. Vaghef B. Hellman D.L Eizirik Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death FEBS Lett 394 1996 300 306
102. W.L Suarez-Pinzon C. Szabó A. Rabinovitch Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β-cells Diabetes 46 1997 907 911
103. M. Solimena P. De Camilli Spotlight on a neuronal enzyme Nature 366 1993 15 17
104. D.L Kaufman M. Clare-Salzler J. Tian T. Forsthuber G.S.P Ting P. Robinson M.A Atkinson E.E Sercarz A.J Tobin P.V Lehmann Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes Nature 366 1993 69 72
105. R. Tisch X.-D Yang S.M. Singer R.S. Liblau L. Fugger H.O McDevitt Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice Nature 366 1993 72 75
106. L.C Harrison M.C Honeyman H.J DeAizpurua R.S. Schmidli P.G Colman B.D Tait D.S. Cram Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes Lancet 341 1993 1365 1369
107. L. Yu R. Gianani G.S. Eisenbarth Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes Diabetes 43 1994 1229 1233
108. V. Ramiya A. Muir N. Maclaren Insulin prophylaxis in insulin-dependent diabetes mellitus Immunological rationale and therapeutic use Clin Immunother 3 1995 177 183
109. B.O Roep A.A Kallan W.L Hazenbos G.J Bruining E.M. Bailyes S.D Arden J.C Hutton R.R. de Vries T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes Lancet 337 1991 1439 1441
110. S.D Arden B.O Roep P.I Neophytou E.F. Usac G. Duinkerken R.R.P de Vries J.C Hutton Imogen 38 A novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient J Clin Invest 97 1996 551 561
111. R.H Slover G.S. Eisenbarth Prevention of Type 1 diabetes and recurrent β-cell destruction of transplanted islets Endocr Rev 18 1997 241 258
112. D.J Lenschow S.C Ho H. Sattar L. Rhee G. Gray N. Nabavi K.C Herold J.A Bluestone Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse J Exp Med 181 1995 1145 1155
113. X.X Zheng A.W. Steele W.W. Hancock A.C Stevens P.W. Nickerson P. Roy-Chaudhury Y. Tian T.B Strom A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice J Immunol 158 1997 4507 4513
114. T. Mandrup-Poulsen J.I Reimers H.U Andersen F. Pociot A.E Karlsen U. Bjerre J. Nerup Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus Diabetes Metab Rev 9 1993 295 309
115. G.J Southan C. Szabó Selective pharmacological inhibition of distinct nitric oxide synthase isoforms Biochem Pharmacol 51 1996 383 394
116. C. Szabó R. Bryk B. Zingarelli G.J Southan T.C Gahman V. Bhat A.L Salzman D.J Wolff Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform Br J Pharmacol 118 1996 1659 1668